Learn More
Epredia™ Lab Vision™ NY-BR-1 Mouse Monoclonal Antibody
Take advantage of a quality product that delivers accurate results with the Epredia™ NY-BR-1, Mouse Monoclonal Antibody.
Supplier: Epredia™ MS1932P
Description
NY-BR-1 is a novel differentiation marker predominantly expressed in normal breast and breast cancer. It has been shown by Immunohistochemistry (IHC) that NY-BR-1 was present solely in ductal epithelium of normal breast tissue. Invasive carcinoma of the breast and carcinoma in situ were positive for NY-BR-1, whereas most other tumors and normal tissues are negative, with the exceptions of one-third of sweat gland carcinomas and around two percent of prostate carcinoma. NY-BR-1 is reported to express more frequently in estrogen-positive and lymph node-negative primary carcinomas, and more commonly in grade 1 than in grade 2 or grade 3. In a study by Varga et al (2006) forty-nine percent of lymph node metastasis were shown to be positive.Host Species: Mouse
Clone: NY-BR-1No. 2
Isotype: IgG1/κ
Species Reactivity: Human. Others not tested.
Epitope: Not determined
Immunogen: a 77 aa peptide from human NYBR-1 protein
Molecular Weight: 150-160kDa
Positive Control: Breast carcinoma
Cellular Localization: Predominantly cytoplasmic and occasional nuclear
Recommended for:
Immunohistochemistry (Formalin/paraffin)
Specifications
NY-BR-1 | |
NY-BR-1 No.2 | |
Unconjugated | |
a 77 aa peptide from human NYBR-1 protein | |
Primary | |
Purified |
Immunohistochemistry | |
200μg/mL | |
Mouse | |
1 mL | |
Human |
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.